Cargando…

Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children

Vaccination remains the most effective and cost-saving measure to protect against hepatitis B, a global health problem. It is crucial to characterize the persistence of the immune response after booster vaccination. This study aimed to quantify the persistence through mathematical modeling. Booster...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Yan, Wu, Zi-Kang, Wu, Jie, Yao, Jun, Liu, Ying, Ren, Wen, Sun, Yu-Jing, Shen, Ling-Zhi, Ren, Jing-Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Hepatitis – Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897632/ https://www.ncbi.nlm.nih.gov/pubmed/35507912 http://dx.doi.org/10.1080/21645515.2022.2061247

Ejemplares similares

Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction
por: Wang, Xiaoli, et al.
Publicado: (2023)

Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control
por: Yan, Bingyu, et al.
Publicado: (2023)

Knowledge and awareness of viral hepatitis and influencing factors among the general population aged 15–69 years in Zhejiang Province, China
por: Zhou, Yang, et al.
Publicado: (2023)

Profile of clinical characteristics and serologic markers of sporadic hepatitis E in a community cohort study
por: Tang, Zi-Min, et al.
Publicado: (2022)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
por: Lin, Kuan-Yin, et al.
Publicado: (2023)

Specific determination of hepatitis B e antigen by antibodies targeting precore unique epitope facilitates clinical diagnosis and drug evaluation against hepatitis B virus infection
por: Wang, Shao-Juan, et al.
Publicado: (2021)

Viral quasispecies quantitative analysis: a novel approach for appraising the immune tolerant phase of chronic hepatitis B virus infection
por: Wang, Mingjie, et al.
Publicado: (2021)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Intrahepatic transcriptomics reveals gene signatures in chronic hepatitis B patients responded to interferon therapy
por: Li, Ning, et al.
Publicado: (2022)

Hepatitis C microelimination among people living with HIV in Taiwan
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment
por: Yin, Shengxia, et al.
Publicado: (2023)

Safety of hepatitis E vaccination for pregnancy: a post-hoc analysis of a randomized, double-blind, controlled phase 3 clinical trial
por: Zhong, Guohua, et al.
Publicado: (2023)

TEMPORAL TRENDS IN THE DETECTION RATES OF HEPATITIS B IN THE SANTA CATARINA STATE, BRAZIL
por: Marcon, Chaiana Esmeraldino Mendes, et al.
Publicado: (2014)

Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection
por: Jiang, Xinyi, et al.
Publicado: (2022)

CRISPR/Cas13a-assisted rapid and portable HBV DNA detection for low-level viremia patients
por: Tian, Yuan, et al.
Publicado: (2023)

Human hepatocyte-enriched miRNA-192-3p promotes HBV replication through inhibiting Akt/mTOR signalling by targeting ZNF143 in hepatic cell lines
por: Li, Fahong, et al.
Publicado: (2022)

A standardized assay for the quantitative detection of serum HBV RNA in chronic hepatitis B patients
por: Yu, Guangxin, et al.
Publicado: (2022)

Prevalence of antibody to hepatitis B surface antigen among qualified blood donors in Nanjing, China
por: Zhou, Yi-Hua, et al.
Publicado: (2023)

Molecular epidemiology and genotype-specific disease severity of hepatitis E virus infections in Germany, 2010–2019
por: Schemmerer, Mathias, et al.
Publicado: (2022)

HEPATITIS B VACCINATION COVERAGE AND POSTVACCINATION SEROLOGIC TESTING AMONG MEDICAL STUDENTS AT A PUBLIC UNIVERSITY IN BRAZIL
por: de Souza, Eduardo Pernambuco, et al.
Publicado: (2014)

Enhanced monitoring and detection of recent genotype 3 hepatitis E virus infection through urine antigen testing
por: Stahl, Yannick, et al.
Publicado: (2023)

Sexually-transmitted hepatitis C virus reinfections among people living with HIV in Taiwan: the emerging role of genotype 6
por: Chen, Guan-Jhou, et al.
Publicado: (2022)

High hepatitis B vaccination coverage among a cohort of predominantly men who have sex with men in Germany
por: Esber, Allahna L., et al.
Publicado: (2023)

Hepatitis B virus promotes its own replication by enhancing RAB5A-mediated dual activation of endosomal and autophagic vesicle pathways
por: Zhao, Zhenyu, et al.
Publicado: (2023)

The positive rates of hepatitis B surface antibody in youth after booster vaccination: a 4-year follow-up study with large sample
por: Zhu, Xia, et al.
Publicado: (2021)

Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort
por: Papastergiou, V, et al.
Publicado: (2014)

Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single‐arm, open‐label, phase 3 trial
por: Gao, Yanhang, et al.
Publicado: (2020)

HCV INFECTION THROUGH PERFORATING AND CUTTING MATERIAL AMONG CANDIDATES FOR BLOOD DONATION IN BELÉM, BRAZILIAN AMAZON
por: Valois, Rubenilson Caldas, et al.
Publicado: (2014)

HIV AND HCV COINFECTION: PREVALENCE, ASSOCIATED FACTORS AND GENOTYPE CHARACTERIZATION IN THE MIDWEST REGION OF BRAZIL
por: Freitas, Solange Zacalusni, et al.
Publicado: (2014)

The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
por: Jiang, Shaowen, et al.
Publicado: (2023)

Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies
por: Piermatteo, Lorenzo, et al.
Publicado: (2023)

Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1‐infected patients without cirrhosis: OPTIMIST‐1, a phase 3, randomized study
por: Kwo, Paul, et al.
Publicado: (2016)

Hepatitis E virus and fulminant hepatitis–a virus or host-specific pathology?
por: Smith, Donald B, et al.
Publicado: (2015)

La hepatitis A aguda
por: Maier, Klaus-Peter
Publicado: (1994)

Hepatitis viral
por: Krugman, Saul, 1911-
Publicado: (1979)

Chronic Hepatitis E is associated with cholangitis
por: Beer, Andrea, et al.
Publicado: (2019)

Histological changes in HCV antibody–positive, HCV RNA–negative subjects suggest persistent virus infection
por: Hoare, Matthew, et al.
Publicado: (2008)

Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan
por: Chen, Chi‐Yi, et al.
Publicado: (2021)

Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice
por: Korenaga, Masaaki, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_urffmrbvf882k4g8lik2905sih